SLC41A2

gene
On this page

Also known as DKFZP434K0427

Summary

SLC41A2 (solute carrier family 41 member 2, HGNC:31045) is a protein-coding gene on chromosome 12q23.3, encoding Solute carrier family 41 member 2 (Q96JW4). Acts as a plasma-membrane magnesium transporter.

Predicted to enable magnesium ion transmembrane transporter activity. Involved in magnesium ion transport. Located in plasma membrane.

Source: NCBI Gene 84102 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 97 total
  • MANE Select transcript: NM_001352171

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31045
Approved symbolSLC41A2
Namesolute carrier family 41 member 2
Location12q23.3
Locus typegene with protein product
StatusApproved
AliasesDKFZP434K0427
Ensembl geneENSG00000136052
Ensembl biotypeprotein_coding
OMIM610802
Entrez84102

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 18 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000258538, ENST00000411411, ENST00000415674, ENST00000417469, ENST00000424946, ENST00000432951, ENST00000433540, ENST00000437220, ENST00000449866, ENST00000549713, ENST00000906846, ENST00000906847, ENST00000906848, ENST00000906849, ENST00000906850, ENST00000906851, ENST00000906852, ENST00000906853, ENST00000963050

RefSeq mRNA: 11 — MANE Select: NM_001352171 NM_001352169, NM_001352170, NM_001352171, NM_001352172, NM_001387125, NM_001387126, NM_001387127, NM_001387128, NM_001387129, NM_001387130, NM_032148

CCDS: CCDS9100

Canonical transcript exons

ENST00000258538 — 11 exons

ExonStartEnd
ENSE00000922975104845843104845974
ENSE00000922976104861291104861370
ENSE00000922978104886293104886439
ENSE00000922980104895274104895345
ENSE00000922981104909655104909762
ENSE00000937858104866432104866579
ENSE00000937859104844472104844620
ENSE00001255321104927973104928694
ENSE00001650772104801801104805337
ENSE00003790761104889033104889177
ENSE00003916167104958088104958290

Expression profiles

Bgee: expression breadth ubiquitous, 226 present calls, max score 95.00.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0878 / max 147.2639, expressed in 1371 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1330196.84261253
1330201.2452649

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370195.00gold quality
jejunal mucosaUBERON:000039994.73gold quality
secondary oocyteCL:000065593.20gold quality
ileal mucosaUBERON:000033192.94gold quality
duodenumUBERON:000211492.56gold quality
epithelial cell of pancreasCL:000008392.45gold quality
colonic epitheliumUBERON:000039792.45gold quality
liverUBERON:000210792.38gold quality
right lobe of liverUBERON:000111491.60gold quality
islet of LangerhansUBERON:000000690.32gold quality
adrenal tissueUBERON:001830390.22gold quality
parotid glandUBERON:000183188.41gold quality
corpus epididymisUBERON:000435988.20gold quality
cartilage tissueUBERON:000241888.00gold quality
descending thoracic aortaUBERON:000234587.90gold quality
germinal epithelium of ovaryUBERON:000130487.61gold quality
rectumUBERON:000105286.68gold quality
pancreasUBERON:000126486.67gold quality
stomachUBERON:000094586.59gold quality
spermCL:000001986.54gold quality
colonic mucosaUBERON:000031786.29gold quality
body of stomachUBERON:000116186.26gold quality
mucosa of transverse colonUBERON:000499185.73gold quality
thoracic aortaUBERON:000151585.71gold quality
ascending aortaUBERON:000149685.52gold quality
gall bladderUBERON:000211085.49gold quality
tendonUBERON:000004385.19gold quality
mucosa of sigmoid colonUBERON:000499385.12gold quality
body of pancreasUBERON:000115084.74gold quality
seminal vesicleUBERON:000099883.83gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-ANND-3yes11.39
E-MTAB-8498yes9.15
E-MTAB-2983no479.94

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

96 targeting SLC41A2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-126-5P100.0072.713180
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-3689D100.0066.141181
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-656-3P100.0072.152788
HSA-MIR-3646100.0073.565283
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-186-5P99.9970.833707
HSA-MIR-366299.9973.825684
HSA-MIR-450099.9972.722367
HSA-MIR-453499.9966.581907
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548P99.9872.253784
HSA-MIR-477599.9875.006394
HSA-MIR-3617-3P99.9867.86918
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-590-3P99.9674.346478
HSA-MIR-365899.9673.874379
HSA-MIR-448799.9664.581252
HSA-MIR-545-3P99.9570.742783

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_rerioslc41a2bENSDARG00000073881
danio_rerioslc41a2aENSDARG00000075803
mus_musculusSlc41a2ENSMUSG00000034591
rattus_norvegicusSlc41a2ENSRNOG00000008713
drosophila_melanogasterCG33181FBGN0053181
caenorhabditis_elegansZK1053.6WBGENE00014201
caenorhabditis_elegansWBGENE00019504
caenorhabditis_elegansWBGENE00022682

Paralogs (2): SLC41A3 (ENSG00000114544), SLC41A1 (ENSG00000133065)

Protein

Protein identifiers

Solute carrier family 41 member 2Q96JW4 (reviewed: Q96JW4)

All UniProt accessions (9): C9J2P6, C9JA64, C9JCR2, C9JDQ2, Q96JW4, C9JIL4, C9JKF2, C9JYJ7, H7BZT9

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a plasma-membrane magnesium transporter. Can also mediate the transport of other divalent metal cations in an order of Ba(2+) > Ni(2+) > Co(2+) > Fe(2+) > Mn(2+).

Subcellular location. Cell membrane.

Similarity. Belongs to the SLC41A transporter family.

RefSeq proteins (11): NP_001339098, NP_001339099, NP_001339100, NP_001339101, NP_001374054, NP_001374055, NP_001374056, NP_001374057, NP_001374058, NP_001374059, NP_115524 (=MANE)

Domains & families (InterPro)

IDNameType
IPR006667SLC41_membr_domDomain
IPR036739SLC41_membr_dom_sfHomologous_superfamily
IPR045349SLC41A1-3Family

Pfam: PF01769

Catalyzed reactions (Rhea), 5 shown:

  • Fe(2+)(in) = Fe(2+)(out) (RHEA:28486)
  • Co(2+)(in) = Co(2+)(out) (RHEA:28578)
  • Mn(2+)(in) = Mn(2+)(out) (RHEA:28699)
  • Mg(2+)(in) = Mg(2+)(out) (RHEA:29827)
  • Ni(2+)(in) = Ni(2+)(out) (RHEA:29831)

UniProt features (27 total): topological domain 12, transmembrane region 11, modified residue 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96JW4-F172.690.39

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 136, 137

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-425410Metal ion SLC transporters
R-HSA-382551Transport of small molecules
R-HSA-425366
R-HSA-425407SLC-mediated transmembrane transport

MSigDB gene sets: 184 (showing top): GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_MAGNESIUM_ION_TRANSPORT, GOBP_IRON_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, AAACCAC_MIR140, TCF11_01, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, GOBP_TRANSMEMBRANE_TRANSPORT, PITX2_Q2, HOWLIN_CITED1_TARGETS_2_DN, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, chr12q23

GO Biological Process (11): cobalt ion transport (GO:0006824), iron ion transport (GO:0006826), manganese ion transport (GO:0006828), nickel cation transport (GO:0015675), magnesium ion transport (GO:0015693), monoatomic ion transport (GO:0006811), monoatomic cation transport (GO:0006812), metal ion transport (GO:0030001), transmembrane transport (GO:0055085), monoatomic cation transmembrane transport (GO:0098655), magnesium ion transmembrane transport (GO:1903830)

GO Molecular Function (4): magnesium ion transmembrane transporter activity (GO:0015095), protein binding (GO:0005515), monoatomic cation transmembrane transporter activity (GO:0008324), obsolete inorganic cation transmembrane transporter activity (GO:0022890)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
SLC-mediated transmembrane transport1
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transition metal ion transport4
monoatomic cation transmembrane transport3
transport2
monoatomic cation transport2
metal ion transport1
monoatomic ion transport1
cellular process1
monoatomic ion transmembrane transport1
magnesium ion transport1
metal ion transmembrane transporter activity1
magnesium ion transmembrane transport1
binding1
monoatomic ion transmembrane transporter activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

612 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC41A2TRPM6Q9BX84755
SLC41A2TRPM7Q96QT4737
SLC41A2MRS2Q9HD23692
SLC41A2CNNM2Q9H8M5671
SLC41A2MAGT1Q9H0U3616
SLC41A2CNNM1Q9NRU3598
SLC41A2NIPAL3Q6P499507
SLC41A2CNNM3Q8NE01498
SLC41A2NIPA1Q7RTP0495
SLC41A2CNNM4Q6P4Q7477
SLC41A2SLC35H1Q9NQQ7474
SLC41A2NIPAL1Q6NVV3467
SLC41A2CLDN16Q9Y5I7461
SLC41A2NIPA2Q8N8Q9460
SLC41A2SLC38A6Q8IZM9458

IntAct

101 interactions, top by confidence:

ABTypeScore
SLC41A2KASH5psi-mi:“MI:0915”(physical association)0.720
KASH5SLC41A2psi-mi:“MI:0915”(physical association)0.720
SLC41A2HHLA2psi-mi:“MI:0915”(physical association)0.560
SLC41A2AMIGO1psi-mi:“MI:0915”(physical association)0.560
SLC41A2SLC6A15psi-mi:“MI:0915”(physical association)0.560
SLC41A2SHISAL1psi-mi:“MI:0915”(physical association)0.560
SLC41A2GPR42psi-mi:“MI:0915”(physical association)0.560
SLC41A2LYVE1psi-mi:“MI:0915”(physical association)0.560
SSMEM1SLC41A2psi-mi:“MI:0915”(physical association)0.560
SLC41A2MFFpsi-mi:“MI:0915”(physical association)0.560
FATE1SLC41A2psi-mi:“MI:0915”(physical association)0.560
LDLRAD1SLC41A2psi-mi:“MI:0915”(physical association)0.560
IGFBP5SLC41A2psi-mi:“MI:0915”(physical association)0.560
FUT3SLC41A2psi-mi:“MI:0915”(physical association)0.560
CLN5SLC41A2psi-mi:“MI:0915”(physical association)0.560
PVRSLC41A2psi-mi:“MI:0915”(physical association)0.560
ERVFRD-1SLC41A2psi-mi:“MI:0915”(physical association)0.560
SHISAL1SLC41A2psi-mi:“MI:0915”(physical association)0.560
LEUTXSLC41A2psi-mi:“MI:0915”(physical association)0.560

BioGRID (43): CCDC155 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Synthetic Lethality), SLC41A2 (Affinity Capture-RNA), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), SLC41A2 (Two-hybrid), KIAA1644 (Two-hybrid)

ESM2 similar proteins: A0A2K1ZPK4, A0A2K2AIF4, A0A2K2BF92, B9GNS0, B9H7I1, E7EXX2, O22881, O54902, O77741, P41251, P49279, P49280, P49281, P49282, P49283, P51027, P56436, P70553, Q0D7E4, Q21433, Q21434, Q27946, Q27981, Q4R335, Q5QN13, Q5ZHX6, Q6DFC0, Q6DIV6, Q6PF45, Q6YWQ4, Q6ZG85, Q7XIV8, Q869V1, Q8BGY9, Q8BYR8, Q8H3P9, Q8H4H5, Q8UWF0, Q8VDT1, Q8VXB5

Diamond homologs: E7EXX2, Q3SWT5, Q4R335, Q5R839, Q5ZHX6, Q6DFC0, Q8BJA2, Q8BYR8, Q8IVJ1, Q921R8, Q96GZ6, Q96JW4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

97 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance59
Likely benign1
Benign24

Top pathogenic / likely-pathogenic (0)

SpliceAI

1760 predictions. Top by Δscore:

VariantEffectΔscore
12:104861366:CAATG:Cacceptor_gain1.0000
12:104861369:TG:Tacceptor_gain1.0000
12:104909653:A:ACdonor_gain1.0000
12:104909654:C:CCdonor_gain1.0000
12:104909654:CTG:Cdonor_gain1.0000
12:104909654:CTGCA:Cdonor_gain1.0000
12:104927970:CA:Cdonor_loss1.0000
12:104927971:A:ATdonor_loss1.0000
12:104844530:C:CTdonor_gain0.9900
12:104844618:CTC:Cacceptor_gain0.9900
12:104845837:ACAT:Adonor_loss0.9900
12:104845838:CATA:Cdonor_loss0.9900
12:104845840:TA:Tdonor_loss0.9900
12:104845841:ACC:Adonor_loss0.9900
12:104845842:C:CGdonor_loss0.9900
12:104845971:ATACC:Aacceptor_loss0.9900
12:104845972:TAC:Tacceptor_gain0.9900
12:104845972:TACC:Tacceptor_loss0.9900
12:104845973:ACCTG:Aacceptor_loss0.9900
12:104845974:CCTGA:Cacceptor_loss0.9900
12:104845975:C:Aacceptor_loss0.9900
12:104845976:T:Aacceptor_loss0.9900
12:104861285:TCTTA:Tdonor_loss0.9900
12:104861286:CT:Cdonor_loss0.9900
12:104861287:TTA:Tdonor_loss0.9900
12:104861288:TACC:Tdonor_loss0.9900
12:104861289:A:ACdonor_gain0.9900
12:104861289:A:Cdonor_loss0.9900
12:104861290:C:CCdonor_gain0.9900
12:104861367:AATG:Aacceptor_gain0.9900

AlphaMissense

3754 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:104805225:C:TG550E1.000
12:104805226:C:AG550W1.000
12:104805226:C:GG550R1.000
12:104805226:C:TG550R1.000
12:104805234:T:GD547A1.000
12:104805249:A:GL542P1.000
12:104845929:G:AT434I1.000
12:104845938:C:AR431M1.000
12:104845940:G:CS430R1.000
12:104845940:G:TS430R1.000
12:104845942:T:GS430R1.000
12:104845961:A:CN423K1.000
12:104845961:A:TN423K1.000
12:104861353:A:GL398P1.000
12:104866447:G:TA387D1.000
12:104866466:A:GW381R1.000
12:104866466:A:TW381R1.000
12:104886348:G:CD324E1.000
12:104886348:G:TD324E1.000
12:104886349:T:AD324V1.000
12:104886349:T:CD324G1.000
12:104886349:T:GD324A1.000
12:104886350:C:GD324H1.000
12:104886352:C:AG323V1.000
12:104886352:C:TG323D1.000
12:104886353:C:AG323C1.000
12:104886353:C:GG323R1.000
12:104886357:A:CS321R1.000
12:104886357:A:TS321R1.000
12:104886359:T:GS321R1.000

dbSNP variants (sampled 300 via entrez): RS1000005611 (12:104928784 AAC>A), RS1000013041 (12:104831738 T>C), RS1000015644 (12:104835252 T>C), RS1000067864 (12:104834950 T>G), RS1000082940 (12:104842494 T>A), RS1000093863 (12:104889737 G>A,C), RS1000157100 (12:104956553 C>A), RS1000157860 (12:104921987 T>A), RS1000163075 (12:104805707 A>C), RS1000168948 (12:104864846 C>G), RS1000248494 (12:104958265 T>C), RS1000280241 (12:104951544 A>G), RS1000319081 (12:104903907 A>G), RS1000323053 (12:104816025 G>C), RS1000364234 (12:104949810 C>T)

Disease associations

OMIM: gene MIM:610802 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST010923_11Beta blocker survival benefit in heart failure with reduced ejection fraction (time to all cause mortality x beta blocker interaction)8.000000e-06
GCST011998_10Glucocorticoid receptor gene expression in B-cell precursor acute lymphoblastic leukaemia9.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004352mortality
EFO:0007766response to beta blocker

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC41 family of divalent cation transporters

CTD chemical–gene interactions

44 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, affects expression, decreases methylation6
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression3
potassium chromate(VI)affects cotreatment, decreases expression2
Cyclosporineincreases expression2
Aflatoxin B1decreases expression, decreases methylation2
aristolochic acid Idecreases expression1
bisphenol Aincreases expression1
trichostatin Aincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
perfluorooctanoic acidincreases expression1
manganese chlorideincreases expression, affects cotreatment, increases abundance1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
chromium hexavalent iondecreases expression1
entinostatincreases expression1
dimethylarsinous acidincreases expression1
2,2’,4,4’,5-brominated diphenyl etherincreases expression1
3,4,5,4’-tetramethoxystilbeneaffects expression1
abrineincreases expression1
jinfukangdecreases expression1
(+)-JQ1 compoundincreases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Calcitriolincreases expression, affects cotreatment1
Dimethyl Sulfoxideincreases expression1
Doxorubicindecreases expression1
Leadaffects expression1

Cellosaurus cell lines

3 cell lines: 3 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4NYHCT116-SLC41A2-KO-c4Cancer cell lineMale
CVCL_D4NZHCT116-SLC41A2-KO-c6Cancer cell lineMale
CVCL_TN67HAP1 SLC41A2 (-)Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.